Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy
- 1 July 2003
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 56 (4) , 1161-1169
- https://doi.org/10.1016/s0360-3016(03)00161-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Measurement of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Blood and Tissues: Clinical and Experimental ApplicationsAnnals of the New York Academy of Sciences, 1999
- Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastasesBritish Journal of Cancer, 1995
- Plasma assay of gelatinase B:Tissue inhibitor of metalloproteinase complexes in cancerCancer, 1995
- Serum metalloproteinases and their inhibitors: markers for malignant potentialBritish Journal of Cancer, 1994
- The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Immunoassay of type IV collagenase / gelatinase (MMP-2) in human plasmaJournal of Immunological Methods, 1992
- Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure total collagenaseMatrix, 1992
- Immunoassays for the Detection of Human Collagenase, Stromelysin, Tissue Inhibitor of Metallo-proteinases (TIMP) and Enzyme-Inhibitor ComplexesMatrix, 1990
- Workshop on Techniques to Evaluate Lung Alveolar-Microvascular InjuryAmerican Review of Respiratory Disease, 1990
- Radiation effects in the lung.Environmental Health Perspectives, 1986